214 related articles for article (PubMed ID: 32547859)
1. Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis.
Dai D; Wang Y; Zhu L; Jin H; Wang X
PeerJ; 2020; 8():e9149. PubMed ID: 32547859
[TBL] [Abstract][Full Text] [Related]
2. Predictive and Prognostic Assessment Models for Tumor Deposit in Colorectal Cancer Patients With No Distant Metastasis.
Chen J; Zhang Z; Ni J; Sun J; Ren W; Shen Y; Shi L; Xue M
Front Oncol; 2022; 12():809277. PubMed ID: 35251979
[TBL] [Abstract][Full Text] [Related]
3. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World.
Zhang S; Wang Y; Zhang P; Ai L; Liu T
Front Cardiovasc Med; 2022; 9():851833. PubMed ID: 35783821
[TBL] [Abstract][Full Text] [Related]
5. KRAS Sequence Variation as Prognostic Marker in Patients With Young- vs Late-Onset Colorectal Cancer.
Aljehani MA; Bien J; Lee JSH; Fisher GA; Lin AY
JAMA Netw Open; 2023 Nov; 6(11):e2345801. PubMed ID: 38032636
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of very early onset pancreatic cancer: a population-based analysis.
Dai D; Wang Y; Hu X; Jin H; Wang X
PeerJ; 2020; 8():e8412. PubMed ID: 32095324
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.
Zhang J; Gong Z; Gong Y; Guo W
Jpn J Clin Oncol; 2019 May; 49(5):438-446. PubMed ID: 30924498
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with resected primary colorectal mucinous adenocarcinoma: A competing risk nomogram analysis.
Dai D; Zhou B; Zhong Y; Jin H; Wang X
Oncol Lett; 2019 Dec; 18(6):6594-6604. PubMed ID: 31807175
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection.
Chen Q; Chen J; Deng Y; Zhang Y; Huang Z; Zhao H; Cai J
J Gastrointest Oncol; 2022 Feb; 13(1):171-184. PubMed ID: 35284104
[TBL] [Abstract][Full Text] [Related]
10. A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC.
Li J; Li X; Gu J; Ma X; Xue F
Jpn J Clin Oncol; 2018 Dec; 48(12):1088-1095. PubMed ID: 30257010
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a novel prognostic nomogram including tumor deposits could better predict survival for colorectal cancer: a population-based study.
Bai R; Tan Y; Li D; Yang M; Yu L; Yuan Y; Fang X
Ann Transl Med; 2021 Apr; 9(8):620. PubMed ID: 33987318
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy.
Zhou X; Ning Q; Jin K; Zhang T; Ma X
BMC Cancer; 2020 Feb; 20(1):97. PubMed ID: 32019501
[TBL] [Abstract][Full Text] [Related]
13. Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study.
Wang J; Yang Y; Pan J; Qiu Y; Shen S; Wang W
Jpn J Clin Oncol; 2022 Apr; 52(4):353-361. PubMed ID: 35137118
[TBL] [Abstract][Full Text] [Related]
14. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
15. A multicenter study: predicting KRAS mutation and prognosis in colorectal cancer through a CT-based radiomics nomogram.
Li M; Yuan Y; Zhou H; Feng F; Xu G
Abdom Radiol (NY); 2024 Feb; ():. PubMed ID: 38393357
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a prognostic nomogram for colorectal cancer after surgery.
Li BW; Ma XY; Lai S; Sun X; Sun MJ; Chang B
World J Clin Cases; 2021 Jul; 9(21):5860-5872. PubMed ID: 34368305
[TBL] [Abstract][Full Text] [Related]
18. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
[TBL] [Abstract][Full Text] [Related]
19. Development of a dual-energy spectral CT based nomogram for the preoperative discrimination of mutated and wild-type KRAS in patients with colorectal cancer.
Cao Y; Zhang G; Bao H; Zhang S; Zhang J; Zhao Z; Zhang W; Li W; Yan X; Zhou J
Clin Imaging; 2021 Jan; 69():205-212. PubMed ID: 32920468
[TBL] [Abstract][Full Text] [Related]
20. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
